Clinical outcome of patients with acute myocardial infarction randomized to either coronary stenting plus abciximab or fibrinolysis plus abciximab (STOPAMI-2 Trial)  by Schoemig, Albert et al.
JACC March 6, 2002 
effects is by reducing platelat aggregation and rnicroembolization downstream during 
mechanical reperfusion and thereby preserving the microcirculation. 
Methods: Forty-seven patients with STEMI underwent primary angioplasty and/or stent- 
ing of native coronary arteries. Saphenous venous graft lesions and patients with end- 
stage renal disease were excluded. Twenty-seven (57.5%) patients received standard 
bolus and infusion of abciximab. Angiograms were evaluated by two blinded independent 
reviewers for Myocardial Blush Grade immediately after coronary intervention as follows: 
0, no blush; 1, minimal blush; 2, moderate blush; and 3, normal blush. All patients had 
Thrombolysis In Myocardial Infarction (TIMI) 3 grade flow at the end of the procedure. 
Results: in the abciximab group, 20/27 (74%) patients had MBG of 2-3, compared to 9/20 
(45%) in the non-abciximab group (p<0.05). In diabetics, 5/10 (60%) in the abciximab 
group had a normal blush compared to 0/5 (0%) in the non-abciximab group (p<0.05). 
Conclusion: Abciximab significantly improved myocardial microcirculation, assessed by 
MBG, after primary coronary intervention for acute ST elevation myocardial infarction. 
This effect seemed particularly prominent in the diabetic subgroup. 
1075-44 Comparative Prognostic Value of Myocardial Blush 
Grade and TIMI Frame Count for Clinical Outcome After 
Acute Myocardial Infarction 
phil/Do K. Haaoer. Jan P. Christott, Wolfgang Lepper, Uwe Janssens, Rainer Hoffmann, 
University Hospital RWTH, Aachen, Germany. 
BACKROUND: Angiographic myocardial blush grade (MBG) and corrected TIMI frame 
count (CTFC) have been suggested for evaluation of myocardial reperfusion and predic- 
tion of patient outcome after PTCA for acute myocardial infarction (AMI). The compara- 
tive prognostic value of both parameters for patient outcome is not established. 
METHODS: To evaluate the prognostic value of MBG (0/1: no or minimal blush, 2: mod- 
erate blush, and 3 normal blush) and CTFC (number of cine frames required for dye to 
reach standardized istal landmarks) all 240 patients (82% male, 63±11 years) which 
underwent PTCA for AMI on a native coronary artery at this institution between 1/96 and 
10/99 were included in this study. MBG and CTFC were determined on the final anglo- 
gram after PTCA. Patients were followed up a mean of 3±1 years after AMI to determine 
the occurrence of death. RESULTS: 59 patient died during follow-up. Patients who died 
during follow-up had a significantly lower MBG and a higher CTFC (slower flow) immedi- 
ately after PTCA. MBG (OR=0.48 per 1 grade rise; 95%C1:0.32 - 0.70, p<0.001) and 
CTFC (OR= 1.02 per 1 frame rise; 95% CI: 1.00 - 1.03, p=O.040) were both univariate 
predictors of death. In a multivariate analysis only MBG proved to be a predictor of death 
(OR=0.49; 95% CI= 0.32-0.76, p<0.001). CONCLUSION: Impaired myocardial pedusion 
as determined by a low MBG and slow flow in the infarct related artery evaluated by 
CTFC are both predictors of death during follow-up after PTCA for AMI. However, MBG 
is the stronger predictor of death. 
Parameter Dead Alive p value 
MBG 1.22±1.08 1.90±1.00 <0.001 
CTFC 41.9¢32.5 33.5±24.2 0.036 
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ratory quantitative analysis was performed for seven coronary arterial zones in patients 
having primary coronary intervention for AMI. Three infarct related arterial zones (IRA) 
and four non-infarct related zones were compared at baseline, following balloon angio- 
plasty, stenting and intracoronary nitroprusside (50-100ugm) respectively. Flow was 
determined using corrected TIMI frame counts (CTFC) for each zone following each 
intervention. Results: Average (mean+S.D.) CTFC is listed in the table. Conclusion: 
Microvascular dysfunction contributes to slow flow in the NIRA among patients with AMI. 
Concordant changes in IRA and NIRA flow and normalization ofNIRA flow in response to 
the direct vasodilator nitroprusside suggests an endothelium-independent mechanism 
and a relationship with the microvasculature of the IRA zone. This finding implies that 
improvement of flow to the infarct zone and/or vasodilator therapy may have a role in 
enhancin~ lobal myocardial blood flow in the setting of AMI. 
IRA NIRA 
Baseline 44.3+7.0 
Post PTCA 21.0+2.0 40.4+~2.9 
Post Stent 27.3+1.5 47.7+-24.9 
Nitroprusside 18.3+_5.9 27.3+_5.1 
1075-47 Beneficial Effects of Brain Natriuretlc Peptide in Acute 
Myocardial Ischemia 
I~anthit Khankirawatana. Suwanee Khankirawatana, ,John Lof, Thomas Porter, University 
of Nebraska Medical Center, Omaha, Nebraska. 
Brain natriuretic peptide (BNP) has been found to be elevated in acute myocardial 
ischemia, but its effect in such event is unknown. To determine whether BNP provides 
any benefit in acute ischernia, we studied 12 dogs at baseline, and total coronary artery 
ligation(OCC). Myocardial blood flow (MBF) was assessed by microsphere. Myocardial 
blood velocity (~) and volume (A) were assessed by power pulse inversion contrast 
echo.Results: BNP enhanced MBF of both risk area, especially in subendocardium 
(from 0.13 to 0,3 ml/gm/min, p<.001, figure), and non-occluded regions (from 0.75 to 
1.85 ml/gm/min, p<.001. Conclusion: BNP globally enhances perfusion both in normal 
coronary artery and in acute ischemia by recruiting collateral microcirculation. BNP has a 
great potential for acute myocardial ischemia treatment. 
A MBF 
(ml/gm/nin) 
Baseline-PreBNP 3.55±1.07 3.33+0.75 1.14_-+0.27 
Baseline-BNP 5.84+1.77** 6,35+_1.39** 3.66±1.26** 
OCC-Pre-BNP 1.17_+0.62 1.0±0.42 0.13+0.1 
OCC-BNP 1.41~0.61" 1.63+0.62" 0.26t"0.19" 
*=p<.01**=p<.001 comparing Pre-BNP versus BNP 
1075-45 Intraaortic Balloon Pumping Can Preserve 
Microvascular Integrity and Myocardial Viability in 
Patients With Reperfused Anterior Acute Myocardial 
Infarction 
Xiaobo Huano, Yili Liu, Pingshen Wu, Xiaolin Chen, Jiangqin Zhang, Daogaog Zha, 
Division of Cardiology, Nanfang Hospital, Guangzhou, People's Republic of China. 
Background: Previous studies have suggested that shear stress induced by intra-aortic 
balloon pumping(tABP) might result in the enhancement of NO bioactivity and increase 
blood mixing and provide favorable washing of the chamber walls.The purpose of this 
study was to assess whether IABP exerts beneficial effect on microvascular function and 
functional and clinical outcomes in patients with acute myocardial infarction(AMI). 
Methods: We randomly divided 61 patients with a first anterior AMI into two groups 
,IABP(n=30) and control groups(n=31).All patients received successful coronary angio- 
plasty within 12h the symptom onset and underwent intravenous myocardial contrast 
echocardiography(MCE).ln the IABP group, IABP therapy was performed before primary 
angioplasty and maintained 24 to 48 hours. 
Results: The improvement in regional eft ventricular function ,wall motion score and 
regional wall motion was significantly better in the IABP group than in the control 
group.Intractable congestive heart failure ,malignant ventricular arrhythmia nd pericar- 
dia1 effusion were more frequently found in the control group than in the IABP group(34% 
vs 13%,21% vs 6%,39% vs 8%,p<0.05,respectively).The frequency of sizable MCE no 
reflow phenomenon was significantly lower in the IABP group than in the control 
group(14% vs 35%,p<0.05). 
Conclusion: IABP in conjunction with coronary angioplasty isassociated with better func- 
tional and clinical outcomes compared to aogioplasty alone in patients with an anterior 
AMI. MCE findings imply that an improvement in microvascular function with IABP may 
be attributable to this better outcome. 
1075-46 Contribution of Microvascular Dysfunction to Impaired 
Flow in the Noninfarct Related Artery: Observations 
During Primary Intervention and Following 
Intracoronary Nitroprusside 
Steven T. Lee, Nicholas J. Miele, Barry L. Sharaf, David O. Williams, Rhode/s/and 
Hospital, Brown University, Providence, Rhode Island. 
Background: In the setting of acute myocardial infarction (AMI), angiographic velocity 
measurements indicate inappropriate slow flow in non-infarct related arteries (NIRA). 
The mechanism of this finding is unknown. We tested the hypothesis that microvascular 
dysfunction of the NIRA is at least in pad responsible. Methods: Angiographic ore labo- 
OCC OCC with BNP 
1075-48 Clinical Outcome of Patients With Acute Myocardial 
Infarction Randomized to Either Coronary Stanting Plus 
Abciximab or Fibrinolysis Plus Abciximab (STOPAMI-2 
Trial) 
Albert Schoemia. Adnan Kastrati, Julinda Mehilli, Josef Dirschinger, Ullrich Schricke, Jodi 
Neverve, JL~rgen Pache, Stefan Mart/nod, Franz-Josef Neumann, Stephan NekoUa, 
Rudolf Bias/n/, Melchior Seyfarth, Markus Schwaiger, Deutsches Herzzentrum, Munich, 
Germany, 1. Med. K/inik rechts der Isar, Munich, Germany. 
Background: Patients with acute myocardial infarction may benefit from the addition of 
glycoprotein lib/Ilia inhibitors to fibrinolytic or mechanical reperfusion strategies. We 
aimed to compare 2 repedusion strategies, stenting and fibrinolysis, both combined with 
abciximab, in terms of myocardial salvage and clinical outcome. 
Methods: We enrolled 162 patients with acute myocardial infarction within 12 hours from 
onset of symptoms, assigning 81 patients to stenting plus abciximab and 81 patients to 
alteplase plus abciximab. The primary endpoint was the salvage index defined as the 
ratio between the degree of myocardial salvage and initial peffusion defect measured by 
technetium 99m sestamibi scintigraphy. Additional endpoint was the comparison of the 
incidence of major adverse clinical events between the 2 treatments at 6 and 12 months 
from randomization. 
Results: Salvage index was significantly greater in the stent group (median 0.60, [25th, 
75th pementiles: 0.37, 0.82]) than in the alteplase group (median 0.41, [0.13, 0.58]), 
P=0.001. By 6 months, 4.9% of the stent group and 8.6% of the fibrinolysis group had 
died, relative risk of 0.56 [95% confidence interval, 0.17-1.88], P=0.35. The combined 
incidence of death and recurrent myocardial infarction was 7.4% in the stent and 17.3% 
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in the fibrinolysis group, relative risk of 0.40 [95% confidence interval, 0.16-1.01], 
P=0.053. Results after 1 year will also be presented. 
Conclusions: The results of STOPAMI-2 trial show that in patients with acute myocardial 
infarction, stanting plus abciximab increases the chances of a favorable clinical outcome 
as compared to fibdnolysis plus abciximab. The significantly greater degree of myocar- 
dial salvage is the mechanism of the clinical benefit yielded by stenting plus abciximab. 
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1076-36 Upregu la t ion  of  Anglotensin Subtype Receptor I (AT1) 
and Beta Adrenergic Receptor (Beta 1-AR) and 
Downregulation of AT2, Transforming Growth Factor 
Beta I (TGF-Beta 1), and TGF-Beta Receptor II in Int imal  
Hyperplasla of Intramyocardial Coronary Arteries Distal  
to  a Severe Epicardial Coronary Stenosis 
Huashan Hona, Sergei Aksenov, Xiaoming Guan, Guilan Xiao, Andre Talleyrand, David 
Waters, John 71 Fallon, Chunguang Chen, Newark Beth israel Medical Center, Newark, 
New Jersey, Mount Sinai School of Medicine, New York, New York. 
We have described inward remodeling with intimal hyperplasia and luminal narrowing of 
small intramyocardial coronary arteries (SIMCA) distal to a severe epicardial coronary 
stenosis in pigs. To examine whether changes in AT1, AT2, ~IAR, ~2AR, TGF-~I and 
TGF ~- R II are involved in this arterial remodeling process, we studied 10 pigs with a 4- 
week severe LAD stenosis that reduced flow by -30% (Group 1), and 8 pigs without cor- 
nary stenosis (Group 2). The outer area and lumen area of SIMCA were measured; the 
ratio of lumen/outer area was defined as the % lumen area and used as an index for the 
degree of lumen narrowing. Immunochemical staining was employed to evaluate vascu- 
lar smooth muscle cell (VSMC) proliferation (ki-67) and expression of AT1, AT2, [31-AR, 
132-AR, TGF-~I and TGF-[~ R II in SIMCA walls. Results: The % lumen of SIMCA in 
Group 1 deceased compared with Group 2 (17_+15% vs 38_+13%, p<0.05). Ki67-positive 
ceils in SIMCA of Group 1 increased (5.8 _+ 0.5% vs 0.9 _+ 0.3%, P<0.01), Expression of 
AT1 and ~I-AR in VSMC of SIMCA increased (Figure A & B), whereas AT2 (Figure C & 
D), TGF-131 and TGF-13 R II decreased in Group 1. Conclusions: The growth-promoting 
factors AT1 and ~I-AR were up-regulated and the antiproliferative factors AT2, TGF-131 
and TGF~ R II were down-regulated in intramyocardial coronary arteries distal to a 
severe epicardial coronary stenosis. This may contribute to the VSMC proliferaion and 
inward remodeling in the intramyocardial coronary arteries end create further flow restric- 
tions in ischemic myocardium. 
(C) Normal (Group 2): AT2 
1076-39 Impaired Coronary Collateral Vessel Recruitment in 
Diabetes Mellitus: Evidence for Defective Ischemic 
Tolerance 
Yilmaz Nisanci, Murat Sezer, Berrin Umman, Sabahattin Umman, Huseyin Otiaz, 
Ercument Yilmaz, Faruk Erzengin, Onal Ozsaruhan, Istanbul University, Istanbul Faculty 
of Medicine, Istanbul, Turke~ 
Collateral channel opening is the one of the components of the ischemic tolerance devel- 
oping during subsequent coronary balloon occlusions. The effect of diabetes meliitus 
(DM) on coronary collateral recruitment (CR) is still not known We therefore sought the 
effect of DM on CR in patients with stable angina (SAP) pectoris by using intracoronary 
pressure measurement technique. 
Methods. Study materiel consisted of 44 patients (21 diabetic) with SAP. All of the 
patients had single vessel disease with more than 70% narrowing and underwent stent 
implantation to this vessel. Total and subtotal occlusions were excluded. After angiogra- 
phy, fiber-optic pressure monitoring guide-wire was advanced to the stanosis to be 
dilated. Myocardial fractional flow reserve (FFRmyo) was determined under adenosine 
hyperemia by the ratio of simultaneously measured mean distal pressure to mean aortic 
pressure. During subsequent two 1-min. balloon occlusion, distal pressure was recorded 
as coronary wedge pressure (CWP). Collateral flow index (CFI) was determined by the 
ratio of simultaneously measured CWP (mmHg) to mean aortic pressure (Pa, mmHg). 
JACC March 6, 2002 
Percentage of the improvement in the CFI (first to second occlusion) between two occlu- 
sions was determined for each patient. 
Results 
There was no difference between two groups in terms of pro-intervention FFRmyo (0.54 
+/- 10.2 in DM group and 0.50 +/- 11.2 in non-DM group). The baseline CFI was signifi- 
cantly higher in non-DM group (0.26 +/- 0.09 versus 0.17 +/- 0.08, p<0.03). Beyond this 
finding, mean CFI increased by 17 % (from 0.17 +/- 0.08 to 0.20 +/- 0.09) in DM group 
and by 30 % (from 0.26 +/- 0.09 to 0.34 +/. 0.10) in non-DM group. There was statistically 
significant difference between these two group in terms of improvement in CFI during 
subsequent balloon occlusions (p<0.01). 
Conclusion 
In addition to poor collateral vessels seen in patients with DM, CR is also impaired. This 
finding suggests that DM abolishes ischemic tolerance in terms of CR as well. 
1076-40 Frequency and Determinants of  S i lent  Plaque 
Disruption in Pat ients  With Stab le  Coronary Syndrome 
Yaeino Sun, Shumei Ms, Kyoichi Mizuno, Masamichi Takano, Kouji Seimiya, Kentaro 
Okamatsu, Hiroyuki Kamon, Ryota Uemura, Fumiyuki Ishibashi, Shinya Yokoyama, 
Takayoshi Ohba, Nippon Medical School, Chiba Hokusoh Hospital, Chiba, Japan, China 
Medical Universi~ The Second Clinical College, Shenyang, People's Republic of China, 
Background: Although pathologic and clinical studies have suggested that plaque disrup- 
tion with or without thrombus plays a key role in the development of acute coronary syn- 
drome and sudden progression of atherosclerosis, the prevalence of silent plaque 
disruption and its correlation with coronary risk factors in patients with stable coronary 
syndrome are unclear. The study was designed to clarify the two questions using core- 
nary angioscopy. 
Methods: Seventy-eight consecutive patients with stable coronary syndrome without any 
complaints within three months before the angioscopic study were enrolled in this study. 
We evaluated 49 non-ischemi-related coronary artedes without significant stenosis on 
arteriography in 41 patients. And the presence of silent plaque disruption and coronary 
risk factors were recorded. 
Results: The frequency of silent plaque disruption was 29.3%. Compared with patients 
without silent plaque disruption, glyoohemoglobinAlc elevated in patients with silent 
plaque disruption (5.8i-0.5% versus 5.4~-0.7%, P=0.0003), as was the frequency of dia- 
betes mellitus and hypertension (66.7% versus 10.3%, P=0.001; 83.3% versus 31.0%, 
P=0.005; respectively). Multivariate analysis revealed that the independent predictors of 
silent plaque disruption were: diabetes mellitus and hypertension. 
Conclusions: In patients with stable coronary syndrome, silent plaque disruption of non- 
ischemia-related coronary arteries were commonly observed. Its determinants were dia- 
betes mellitus and hypertension. Therefore, control of diabetes mellitus and hypertension 
may prevent the incidence of silent plaque disruption and reduce the risk of acute coro- 
nary syndromes. 
1076-41 Homocysteine and Coagulation Factors as a Risk 
Factor of Myocardial Infarction at a Young Age 
Masahiko Saioo. Satoshi Abe, Masakazu Ogawa, Sadatoshi Biro, Shinichi Minagoe, 
Tsuminod Yamashita, Tatsuru Matsuoka, Hiroyuki Torii, Hitoshi Toda, Yoshihiko Atsuchi, 
Koushi Mawatari, Ikuro Maruyama, Chuwa Tel, Kagoshima University, Kagoshima, 
Japan, Kagoshima CCU Network, Kagoshima, Japan. 
Background: An increased homocysteine (Hcy) has been reported to be one of the risk 
factors for coronary heart disease. Many investigators recognize the hypercoagulable 
state in hyperhomocyteinemia, but the mechanisms remain still unclear. Purpose and 
Methods: To evaluate the importance of Hcy to the pathogenesis of young myocardial inf- 
arction (MI), we conducted a case-control study in 97 males with first MI <45yr and 148 
age-matched male controls. We measured plasma Hcy and coagulation factors, tissue 
factor (TF), tissue factor pathway inhibitor, AT-Ill, protein C, protein S, factor VII, acti- 
vated factor VII, prothrombin fragment 1+2, and lipoprotain (a). All parameters were 
divided into quantiles, and conventional risk factors, hypertension, hyperlipidemia, diabe- 
tes, and smoking were difined to have or not for statistical analysis. Results: Plasma Hcy 
in cases (11.3+5.3mmol/I) was significantly higher than in controls (8.3+5.0mmo1/I, 
P<0.001). Hcy, TF, AT-Ill, prothrombin frgment 1+2, lipoprotein (a), diabetes, and smok- 
ing were significantly associated with young MI by using multiple logistic regression anal- 
ysis (Table). In stepwise regression analysis, Hcy was the most important determinant of 
young MI (R2=0.17, P<0.001). Hcy had significant positive correlation with TF (r=0.26, 
P=0.012) in cases but not in controls. Conclusion: These findings suggest that increased 
Hcy is an independent risk factor for young MI, mediated via activation of extrinsic coag- 
ulation. 
Odds ratio 95% Confidence Intervals P value 
Homocystaine 2.17 1.60-2.95 <0.001 
Tissue Factor 1.56 t. 18-2.06 0.002 
Antithrombin 0.65 0.50-0.86 0.002 
Fragment 1 +2 1.45 1.11-1.90 0.007 
Lipoprotein (a) 1.33 1.01-1.75 0.046 
Diabetes 3.80 1.16-12.46 0.028 
Smoking 3.12 1.18-8.25 0.022 
